STAAR SURGICAL CO
For the period ended Jan 2, 2026. Filed Mar 3, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2026 · Filed Mar 3, 2026
STAA$23.87-2.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
II. Schedule II — Valuation and Qualifying Accounts and Reserves
| Column A · Column B · Column C - Additions · Column D · Column E | |||||
|---|---|---|---|---|---|
| Description | Balance at Beginning of Year | Charged to costs and expenses | Charged to other accounts | Deductions | Balance at End of Year |
| (in thousands) | |||||
| Allowance for credit losses | $32 | $71 | $— | $20 | $83 |
| Sales return reserve | 6,579 | 24,644 | — | 21,024 | 10,199 |
| Deferred tax asset valuation allowance | 46,804 | — | — | (7,752) | 54,556 |
| $53,415 | $24,715 | $— | $13,292 | $64,838 | |
| Allowance for credit losses | $191 | $9 | $— | $168 | $32 |
| Sales return reserve | 6,174 | 17,754 | — | 17,349 | 6,579 |
| Deferred tax asset valuation allowance | 42,744 | 4,456 | — | 396 | 46,804 |
| $49,109 | $22,219 | $— | $17,913 | $53,415 | |
| Allowance for credit losses | $20 | $171 | $— | $— | $191 |
| Sales return reserve | 5,706 | 15,967 | — | 15,499 | 6,174 |
| Deferred tax asset valuation allowance | 46,977 | 3,318 | — | 7,551 | 42,744 |
| $52,703 | $19,456 | $— | $23,050 | $49,109 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.